Press Releases
Browse Foundation Medicine’s press release archive.
2013 Announcements
- June 2, 2013New Clinical Data Identifies High Frequency of HER2 Alterations across Multiple Solid Tumor Types
- May 31, 2013Actionable Genomic Alterations Identified in 76% of Clinical Cancer Cases Profiled with FoundationOne™
- May 30, 2013 The US Oncology Network Selects med fusion and Foundation Medicine
- May 15, 2013 Foundation Medicine to Present Clinical Data on its FoundationOne(tm) Cancer Genomic Profile at the 2013 ASCO Annual Meeting
- May 2, 2013 Foundation Medicine and Memorial Sloan-Kettering Cancer Center Announce Partnership to Advance Patient Care in Hematologic Cancers
- April 30, 2013 Study Published in Journal of Clinical Oncology Finds High Concordance of Genomic Alterations in NSCLC Primary and Matched Metastatic Tumor Pairs
- April 4, 2013Foundation Medicine and Agios Announce Diagnostic Discovery Collaboration for IDH1 and IDH2 Cancer Metabolism Programs
- March 28, 2013Foundation Medicine to Present Cancer Genomic Research and Clinical Findings at the AACR Annual Meeting 2013
- March 4, 2013Foundation Medicine Receives Accreditation from the College of American Pathologists
- February 15, 2013Foundation Medicine to Present New Data at the 14th Annual AGBT Meeting
- February 7, 2013Foundation Medicine to Present at Upcoming Investor Conferences
- January 23, 2013Foundation Medicine Appoints Steven J, Kafka, Ph.D. as Chief Business Officer
- January 8, 2013Foundation Medicine Expands Series B Financing to $56 Million
- January 2, 2013Foundation Medicine to Present at the 31st Annual J.P. Morgan Healthcare Conference
2012 Announcements
- December 4, 2012 New Clinical Data Highlighting Foundation Medicine's Next-Generation Sequencing Analysis in Breast Cancer to be Presented at SABCS
- November 13, 2012 Foundation Medicine and ARIAD Announce Collaboration for Genomic Chracterization of Patients in AP26113 Oncology Program
- November 12, 2012 Foundation Medicine and AstraZeneca Announce Genomic Profiling Collaboration
- October 9, 2012 Foundation Medicine to Collaborate with Eisai on International Oncology Trial
- September 20, 2012 Foundation Medicine Announces $42.5 Million Series B Financing
- August 6, 2012 Foundation Medicine and Clovis Oncology Announce Diagnostic Collaboration
- June 26, 2012 WIN Consortium to Conduct a Clinical Trial using FoundationOneTM, Foundation Medicine's Comprehensive Genomic Profile for Cancer
- June 7, 2012 Foundation Medicine Enters Extensive Collaboration to Provide Genomic Information for Clinical Oncology Programs
- June 2, 2012 Foundation Medicine Announces New Data Using Next-Generation Sequencing to Detect Cancer-Related Mutations Not Identified By Conventional Methods
- May 31, 2012 Foundation Medicine to Present at Goldman Sachs 33rd Annual Global Healthcare Conference
- May 30, 2012 Foundation Medicine Launches FoundationOneTM
- Read Press Release | Visit FoundationOne.com
- May 16, 2012 New Clinical Data Highlighting Foundation Medicine's Comprehensive Cancer Genomic Profile to be Presented at 2012 ASCO Annual Meeting
- March 27, 2012 New Data Highlighting Foundation Medicine's Next-Generation Sequencing Approach in Clinical Oncology to be Presented at 103rd AACR Annual Meeting 2012
- March 6, 2012 Foundation Medicine Announces Collaboration with Array BioPharma
- February 12, 2012 Foundation Medicine and Dana Farber-Cancer Institute Identify Novel Genomic Alterations in Lung and Colorectal Cancer
- February 1, 2012 Foundation Medicine Recieves CLIA Certification for Its Genomic Sequencing Laboratory
- January 10, 2012 Foundation Medicine Announces Collaboration with Sanofi
2011 Announcements
- November 2, 2011 Foundation Medicine Appoints Medical Oncologist Vincent A. Miller, M.D., as Senior Vice President of Clinical Development
- October 25, 2011 Foundation Medicine Announces Fourth Major Pharmaceutical Company Alliance
- October 18, 2011 Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million;
Kleiner Perkins Caufield & Byers and Google Ventures Join as Investors - September 22, 2011 Data on Foundation Medicine’s Comprehensive Cancer Diagnostic Test Presented at 2011 European Multidisciplinary Cancer Congress
- June 22, 2011 Foundation Medicine to Present Data on Next-Generation Sequencing Approach to Cancer Genome Analysis at Several Upcoming Industry Conferences
- June 16, 2011 Foundation Medicine Appoints Kevin Krenitsky, M.D., as Chief Operating Officer
- June 6, 2011 Foundation Medicine Announces Results Using Next-Generation Sequencing to Detect Cancer-Associated Mutations in Routine Cancer Tissue Samples; Data Presented at ASCO
- May 19, 2011 Foundation Medicine to Present New Data on its Comprehensive Cancer Genomic Test at ASCO 2011 Annual Meeting
- May 17, 2011 Foundation Medicine Announces Clinical Cancer Genomics Collaboration with Celgene
- May 12, 2011 Foundation Medicine Board of Directors Appoints Michael J. Pellini, M.D., President and Chief Executive Officer
- March 23, 2011 Foundation Medicine to Present Data on Proprietary Approach to Optimizing Next-Generation Cancer Genome Sequencing Platform to Enable Clinical Application at RECOMB 2011
- January 19, 2011 Foundation Medicine Appoints Gary Palmer, M.D., as Senior Vice President of Medical Affairs and Commercial Development
- January 4, 2011 Foundation Medicine Announces First Large Pharmaceutical Company Collaboration
2010 Announcements
- November 10, 2010 Foundation Medicine Appoints Molecular Diagnostics Industry Leader Maureen T. Cronin, Ph.D., as Senior Vice President of Research and Product Development
- April 15, 2010 Foundation Medicine Created by Cancer Genomics Pioneers to Help Bring Personalized Cancer Medicine to Routine Clinical Practice
